CBT Cabot Corporation Common Stock

NYSE · Chemicals · SEC EDGAR'da Görüntüle ↗

$86,35

Fiyat · Tem 2, 2026

Temel veriler itibarıyla May 6, 2026

52 Haftlık Aralık

$58–$95

77% of range

Analist Derecelendirmesi

CBT Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

Fiyat

$86.35

Piyasa Değeri

$4.02B

P/E (TTM)

12.6

EPS (TTM)

$6.02

Gelir (TTM)

$3.71B

Temettü Verimi

2.4%

ROE

22.2%

D/E Borç/Özsermaye

0.7

52 Haftlık Aralık

$58 – $95

CBT Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

Gelir ve Net Gelir $3.71B

2016-09-30 → 2025-09-30

Hisse Başına Kâr $6.02

2016-09-30 → 2025-09-30

Serbest Nakit Akışı $391M

2016-09-30 → 2025-09-30

Marjlar 8.9%

2016-09-30 → 2025-09-30

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Metrik

5 Yıllık trend

CBT

Akran Ortalaması

P/E (TTM)

12.6

14.8

P/S (TTM) (F/S (TTM))

1.1

0.7

P/B (F/D)

2.6

1.2

EV / EBITDA

6.3

—

Price / FCF (Fiyat / Serbest Nakit Akışı)

10.3

—

Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC

Metrik

5 Yıllık trend

CBT

Akran Ortalaması

Gross Margin (Brüt Kar Marjı)

25.3%

11.7%

Operating Margin (Faaliyet Kâr Marjı)

16.7%

—

Net Profit Margin (Net Kâr Marjı)

8.9%

-1.5%

ROA

8.8%

-2.9%

ROE

22.2%

-9.4%

ROIC

15.1%

—

Finansal Sağlık Borç, likidite, solventlik — bilanço gücü

Metrik

5 Yıllık trend

CBT

Akran Ortalaması

Debt / Equity (Borç / Öz Sermaye)

0.7

79.0

Current Ratio (Cari Oran)

1.6

2.3

Quick Ratio (Cari Oran)

0.3

—

Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR

Metrik

5 Yıllık trend

CBT

Akran Ortalaması

Revenue YoY (Gelir Yıllık Bazda)

-7.0%

—

Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)

-4.9%

—

Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)

7.3%

—

EPS YoY (EPS YB)

-10.4%

—

Net Income YoY (Net Gelir Yıllık Bazda)

-12.9%

—

Hisse Başı Metrikler Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü

Metrik

5 Yıllık trend

CBT

Akran Ortalaması

EPS (Diluted) (Hisse Başına Kar (Seyreltilmiş))

$6.02

—

Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı

Metrik

5 Yıllık trend

CBT

Akran Ortalaması

Payout Ratio (Temettü Ödeme Oranı)

29.0%

—

Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR

Temettü Verimi

2.4%

Temettü Ödeme Oranı

29.0%

5 Yıllık Temettü CAGR

—

Ex-tarihi	Miktar
29 Mayıs 2026	$0,4730
27 Şubat 2026	$0,4500
28 Kasım 2025	$0,4500
29 Ağustos 2025	$0,4500
30 Mayıs 2025	$0,4500
28 Şubat 2025	$0,4300
29 Kasım 2024	$0,4300
30 Ağustos 2024	$0,4300
31 Mayıs 2024	$0,4300
22 Şubat 2024	$0,4000
22 Kasım 2023	$0,4000
24 Ağustos 2023	$0,4000
25 Mayıs 2023	$0,4000
23 Şubat 2023	$0,3700
23 Kasım 2022	$0,3700
25 Ağustos 2022	$0,3700
26 Mayıs 2022	$0,3700
24 Şubat 2022	$0,3700
24 Kasım 2021	$0,3700
26 Ağustos 2021	$0,3500

CBT Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

TUT 13 analist

Güçlü Al 1 7,7%
Al 0 0,0%
Tut 6 46,2%
Sat 5 38,5%
Güçlü Sat 1 7,7%

12 Aylık Fiyat Hedefi

6 analist · 2026-07-03

Medyan $88.00

Şimdi $86.35

Düşük $70.00

Yüksek $102.00

Medyan hedef $88.00 +1,9%

Ortalama hedef $88.50 +2,5%

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

Ort. Sürpriz

0.07%

Sonraki Rapor

Ağu 03, 2026

Dönem	EPS Gerçek	EPS Tahmin	Sürpriz
31 Mart 2026	$1.61	$1.47	0.14%
31 Aralık 2025	$1.53	$1.42	0.11%
30 Eylül 2025	$1.70	$1.70	0.00%
30 Haziran 2025	$1.90	$1.84	0.06%
31 Mart 2025	$1.90	$1.87	0.03%

Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı

Hisse Sembolü	Piyasa Değeri	P/E	Gelir YoY	Net Kar Marjı	ROE	Brüt Kar Marjı
CBT	$4.02B	12.6	-7.0%	8.9%	22.2%	25.3%
DOW	—	-6.3	-7.0%	-6.1%	-14.9%	—
WLK	—	-6.3	-8.0%	-13.5%	-15.6%	7.3%
HWKN	$3.16B	38.9	11.2%	7.5%	15.7%	22.6%
OLN	$2.37B	-23.7	3.7%	-1.5%	-5.2%	7.4%
PCT	—	—	—	—	—	—
TROX	$661M	-1.4	-5.7%	-16.2%	-29.6%	9.3%
KOP	$527M	9.9	-10.2%	3.0%	10.5%	—
WLKP	—	—	2.7%	4.2%	—	29.8%
KRO	$508M	-4.6	-1.5%	-6.0%	-13.9%	11.5%
ASIX	$465M	9.6	0.31%	3.2%	6.0%	—

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

Gelir Tablosu 16

CBT için Yıllık Gelir Tablosu verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	$3.71B	$3.99B	$3.93B	$4.32B	$3.41B	$2.61B	$3.34B	$3.24B	$2.72B	$2.41B	$2.87B	$3.65B
Cost of Revenue	$2.77B	$3.03B	$3.09B	$3.44B	$2.61B	$2.11B	$2.65B	$2.47B	$2.06B	$1.84B	$2.29B	$2.93B
Gross Profit	$940M	$960M	$839M	$885M	$799M	$500M	$685M	$772M	$657M	$575M	$585M	$721M
R&D Expense	$59M	$63M	$57M	$55M	$56M	$57M	$60M	$66M	$57M	$53M	$58M	$60M
SG&A Expense	$260M	$283M	$253M	$258M	$289M	$292M	$290M	$308M	$262M	$275M	$282M	$326M
Operating Income	$621M	$614M	$526M	$389M	$454M	$21M	$306M	$144M	$338M	$247M	$-317M	$335M
Interest Expense	$76M	$81M	$90M	$56M	$49M	$53M	$59M	$54M	$53M	$54M	$53M	$55M
Other Non-op	$-7M	$-36M	$-16M	$-9M	$-7M	$-9M	$-1M	$17M	$5M	$-7M	$-11M	$25M
Pretax Income	$565M	$529M	$451M	$335M	$406M	$-33M	$255M	$117M	$299M	$191M	$-377M	$308M
Income Tax	$196M	$111M	$-28M	$102M	$123M	$191M	$70M	$193M	$33M	$33M	$-45M	$92M
Net Income	$331M	$380M	$445M	$209M	$250M	$-238M	$157M	$-113M	$248M	$147M	$-334M	$199M
EPS (Basic)	$6.07	$6.79	$7.79	$3.65	$4.35	$-4.21	$2.64	$-1.85	$3.94	$2.34	$-5.27	$3.06
EPS (Diluted)	$6.02	$6.72	$7.73	$3.62	$4.34	$-4.21	$2.63	$-1.85	$3.91	$2.32	$-5.27	$3.03
Shares (Basic)	53,700,000	55,100,000	56,100,000	56,500,000	56,700,000	56,600,000	58,700,000	61,700,000	62,300,000	62,400,000	63,400,000	64,400,000
Shares (Diluted)	54,200,000	55,700,000	56,500,000	56,900,000	56,800,000	56,600,000	58,800,000	61,700,000	62,700,000	62,900,000	63,400,000	65,100,000
EBITDA	$775M	$765M	$670M	$535M	$614M	$179M	$454M	$305M	$491M	$411M	$-134M	$536M

Bilanço 28

CBT için Yıllık Bilanço verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	$258M	$223M	$238M	$206M	$168M	$151M	$169M	$175M	$280M	$200M	$77M	$67M
Inventory	$504M	$552M	$585M	$664M	$523M	$359M	$466M	$511M	$433M	$342M	$397M	$498M
Prepaid Expense	$106M	$97M	$108M	$114M	$89M	$50M	$45M	$63M	$59M	$49M	$54M	$69M
Current Assets	$1.54B	$1.60B	$1.63B	$1.82B	$1.43B	$978M	$1.21B	$1.39B	$1.30B	$1.05B	$1.05B	$1.36B
PP&E (Net)	$1.71B	$1.53B	$1.41B	$1.27B	$1.38B	$1.31B	$1.35B	$1.30B	$1.30B	$1.29B	$1.38B	$1.58B
PP&E (Gross)	$4.41B	$4.08B	$3.83B	$3.55B	$3.88B	$3.69B	$3.55B	$3.52B	$3.60B	$3.43B	$3.38B	$3.71B
Accum. Depreciation	$2.69B	$2.55B	$2.42B	$2.28B	$2.51B	$2.37B	$2.20B	$2.22B	$2.30B	$2.14B	$2.00B	$2.13B
Goodwill	$134M	$133M	$134M	$129M	$140M	$134M	$90M	$93M	$154M	$152M	$154M	$536M
Intangibles	$55M	$53M	$60M	$63M	$100M	$103M	$96M	$98M	$137M	$140M	$153M	$347M
Other Non-current Assets	$180M	$172M	$172M	$178M	$172M	$160M	$58M	$67M	$46M	$40M	$42M	$52M
Total Assets	$3.81B	$3.74B	$3.60B	$3.52B	$3.31B	$2.78B	$3.00B	$3.24B	$3.34B	$3.05B	$3.06B	$4.08B
Accounts Payable	$648M	$495M	$438M	$533M	$480M	$316M	$390M	$446M	$339M	$259M	$274M	$351M
Accrued Liabilities	·	·	·	·	·	$33M	·	·	·	·	·	·
Short-term Debt	$14M	$45M	$174M	$347M	$72M	$14M	$33M	$249M	$7M	$7M	$22M	$44M
Current Liabilities	$957M	$772M	$822M	$1.10B	$1.15B	$529M	$599M	$952M	$742M	$397M	$441M	$630M
Capital Leases	$85M	$88M	$84M	$83M	$84M	$89M	·	·	·	·	·	·
Deferred Tax	$39M	$42M	$50M	$65M	$73M	$58M	$41M	$42M	$38M	$41M	$59M	$68M
Other Non-current Liabilities	$258M	$245M	$231M	$234M	$279M	$286M	$206M	$252M	$245M	$285M	$240M	$291M
Long-term Debt	$1.09B	$1.07B	$1.08B	$1.08B	$1.06B	$1.07B	$1.03B	$747M	$908M	$907M	$958M	$1.01B
Total Debt	$1.13B	$1.14B	$1.28B	$1.44B	$1.16B	$1.11B	$1.06B	$1.00B	$924M	$926M	$993M	$1.07B
Common Stock	$53M	$54M	$55M	$56M	$57M	$57M	$57M	$61M	$62M	$62M	$63M	$64M
Paid-in Capital	·	·	·	·	·	·	·	·	·	·	·	$49M
Retained Earnings	$1.83B	$1.73B	$1.57B	$1.28B	$1.16B	$989M	$1.34B	$1.42B	$1.71B	$1.54B	$1.48B	$1.90B
Treasury Stock	$3M	$3M	$3M	$4M	$4M	$4M	$5M	$7M	$6M	$7M	$8M	$7M
AOCI	$-335M	$-360M	$-362M	$-439M	$-289M	$-351M	$-391M	$-317M	$-259M	$-325M	$-299M	$-64M
Stockholders' Equity	$1.55B	$1.43B	$1.26B	$898M	$947M	$691M	$998M	$1.15B	$1.50B	$1.27B	$1.23B	$1.94B
Liabilities + Equity	$3.81B	$3.74B	$3.60B	$3.52B	$3.31B	$2.78B	$3.00B	$3.24B	$3.34B	$3.04B	$3.08B	$4.08B
Shares Outstanding	52,842,481	54,297,251	55,243,804	56,248,559	56,726,818	56,466,638	57,080,589	60,366,569	61,884,347	62,210,711	62,458,396	64,382,366

Nakit Akışı 18

CBT için Yıllık Nakit Akışı verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
D&A	$154M	$151M	$144M	$146M	$160M	$158M	$148M	$149M	$155M	$161M	$183M	$201M
Stock-based Comp	$24M	$25M	$20M	$23M	$21M	$9M	$11M	$22M	$16M	$17M	$12M	$14M
Deferred Tax	$32M	$-37M	$-156M	$-40M	$9M	$130M	$-27M	$91M	$-31M	$-36M	$-86M	$8M
Restructuring	$11M	$13M	$4M	$3M	$11M	$19M	$16M	$-30M	$25M	$29M	$21M	$29M
Other Non-cash	$124M	$173M	$142M	$-238M	$-183M	$318M	$74M	$149M	$-37M	$100M	$724M	$-107M
Operating Cash Flow	$665M	$692M	$595M	$100M	$257M	$377M	$363M	$298M	$348M	$392M	$499M	$315M
CapEx	$274M	$241M	$244M	$211M	$195M	$200M	$224M	$229M	$147M	$112M	$141M	$171M
Investing Cash Flow	$-298M	$-235M	$-214M	$-118M	$-186M	$-288M	$-94M	$-246M	$-149M	$-104M	$-162M	$-16M
Debt Issued	$15M	$15M	$84M	$394M	$200M	$444M	$352M	$90M	·	$248M	·	$17M
Net Debt Issued	$8M	$-15M	$-6M	$22M	$-22M	$34M	$277M	$-161M	$-2M	$-53M	$-57M	$-6M
Stock Issued	$8M	$20M	$4M	$6M	$6M	$3M	$4M	$22M	$21M	$10M	$4M	$14M
Stock Repurchased	$168M	$172M	$98M	$53M	$3M	$44M	$173M	$142M	$61M	$45M	$101M	$18M
Net Stock Activity	$-160M	$-152M	$-94M	$-47M	$3M	$-41M	$-169M	$-120M	$-40M	$-35M	$-95M	$-4M
Dividends Paid	$96M	$93M	$88M	$84M	$80M	$80M	$80M	$80M	$77M	$65M	$56M	$54M
Financing Cash Flow	$-336M	$-415M	$-403M	$145M	$-60M	$-132M	$-236M	$-141M	$-133M	$-184M	$-256M	$-302M
Net Change in Cash	$35M	$-15M	$32M	$36M	$19M	$-18M	$-6M	$-105M	$80M	$123M	$10M	$-28M
Free Cash Flow	$391M	$451M	$351M	$-111M	$62M	$177M	$139M	$69M	$193M	$280M	$358M	$144M
Levered FCF	$341M	$387M	$255M	$-150M	$28M	$-183M	$96M	$104M	$145M	$235M	$311M	$105M

Kârlılık 8

CBT için Yıllık Kârlılık verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Gross Margin	25.3%	24.0%	21.3%	20.5%	23.4%	19.1%	20.5%	24.1%	24.0%	24.0%	20.4%	19.8%
Operating Margin	16.7%	15.4%	13.4%	9.0%	13.3%	0.80%	9.2%	4.8%	12.4%	10.4%	-11.0%	9.2%
Net Margin	8.9%	9.5%	11.3%	4.8%	7.3%	-9.1%	4.7%	-3.5%	8.9%	6.2%	-11.6%	5.5%
Pretax Margin	15.2%	13.2%	11.5%	7.8%	11.9%	-1.3%	7.6%	3.6%	10.6%	8.1%	-13.1%	8.5%
EBITDA Margin	20.9%	19.1%	17.0%	12.4%	18.0%	6.9%	13.6%	9.4%	18.1%	17.1%	-4.7%	14.7%
ROA	8.8%	10.3%	12.5%	6.1%	8.2%	-8.2%	5.0%	-3.4%	7.6%	4.9%	-9.3%	4.8%
ROE	22.2%	28.3%	41.2%	22.7%	30.5%	-28.2%	14.6%	-8.5%	17.5%	11.9%	-21.0%	10.2%
ROIC	15.1%	18.9%	22.0%	11.6%	15.0%	7.9%	10.8%	-4.7%	12.6%	9.4%	-12.5%	7.8%

Likidite ve Solventlik 5

CBT için Yıllık Likidite ve Solventlik verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Current Ratio	1.6	2.1	2.0	1.6	1.2	1.8	2.0	1.5	1.7	2.7	2.4	2.2
Quick Ratio	0.3	0.3	0.3	0.2	0.1	0.3	0.3	0.2	0.4	0.5	0.2	0.1
Debt / Equity	0.7	0.8	1.0	1.6	1.2	1.6	1.1	0.9	0.6	0.7	0.8	0.6
LT Debt / Equity	0.6	0.8	0.9	1.2	0.8	1.6	1.0	0.6	0.4	0.7	0.8	0.5
Interest Coverage	8.2	7.6	5.8	6.9	9.3	0.4	5.2	2.9	6.3	4.6	-6.0	6.1

Verimlilik 2

CBT için Yıllık Verimlilik verileri
Metrik	Eğilim	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Asset Turnover		1.0	1.1	1.1	1.3	1.1	0.9	1.1	1.0	0.9	0.8	0.8	0.9
Inventory Turnover		5.3	5.3	5.0	5.8	5.9	5.1	5.4	5.2	5.6	5.0	5.1	6.1

Hisse Başına 7

CBT için Yıllık Hisse Başına verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Book Value / Share	$29.33	$26.24	$22.88	$15.96	$16.69	$12.24	$17.48	$19.12	$23.92	$20.48	$19.76	$30.16
Revenue / Share	$68.51	$71.71	$69.58	$75.94	$60.02	$46.18	$56.75	$52.54	$43.33	$38.33	$45.28	$56.02
Cash Flow / Share	$12.27	$12.42	$10.53	$1.76	$4.52	$6.66	$6.17	$4.83	$5.42	$6.23	$7.87	$4.84
Cash / Share	$4.88	$4.11	$4.31	$3.66	$2.96	$2.67	$2.96	$2.90	$4.52	$3.21	$1.23	$1.04
Dividend / Share	·	·	·	·	·	·	·	$1	$1	$1	$1	$1
Dividend Paid / Share	$2	$2	$2	$1	$1	$1	$1	$1	$1	·	·	·
EPS (TTM)	$6.02	$6.72	$7.73	$3.62	$4.34	$-4.21	$2.63	$-1.85	$3.91	$2.32	$-5.27	$3.03

Büyüme Oranları 8

CBT için Yıllık Büyüme Oranları verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue YoY	-7.0%	1.6%	-9.0%	26.8%	30.4%	·	·	·	·	·	·	·
Revenue CAGR 3Y	-4.9%	5.4%	14.6%	·	·	·	·	·	·	·	·	·
Revenue CAGR 5Y	7.3%	·	·	·	·	·	·	·	·	·	·	·
EPS YoY	-10.4%	-13.1%	113.5%	-16.6%	·	·	·	·	·	·	·	·
EPS CAGR 3Y	18.5%	15.7%	·	·	·	·	·	·	·	·	·	·
Net Income YoY	-12.9%	-14.6%	112.9%	-16.4%	·	·	·	·	·	·	·	·
Net Income CAGR 3Y	16.6%	15.0%	·	·	·	·	·	·	·	·	·	·
Dividend CAGR 5Y	3.7%	·	·	·	·	·	·	·	·	·	·	·

Değerleme (TTM) 17

CBT için Yıllık Değerleme (TTM) verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue TTM	$3.71B	$3.99B	$3.93B	$4.32B	$3.41B	$2.61B	$3.34B	$3.24B	$2.72B	$2.41B	$2.87B	$3.65B
Net Income TTM	$331M	$380M	$445M	$209M	$250M	$-238M	$157M	$-113M	$248M	$147M	$-334M	$199M
Market Cap	$4.02B	$6.07B	$3.83B	$3.59B	$2.84B	$2.03B	$2.59B	$3.79B	$3.45B	$3.26B	$1.97B	$3.27B
Enterprise Value	$4.89B	$6.99B	$4.86B	$4.83B	$3.84B	$3.00B	$3.48B	$4.61B	$4.10B	$3.99B	$2.89B	$4.27B
P/E	12.6	16.6	9.0	17.6	11.5	-8.6	17.2	-33.9	14.3	22.6	-6.0	16.8
P/S	1.1	1.5	1.0	0.8	0.8	0.8	0.8	1.2	1.3	1.4	0.7	0.9
P/B	2.6	4.3	3.0	4.0	3.0	2.9	2.6	3.3	2.3	2.6	1.6	1.7
P / Tangible Book	3.0	4.9	3.6	5.1	4.0	4.5	·	·	·	·	·	·
P / Cash Flow	6.0	8.8	6.4	35.9	11.1	5.4	7.1	12.7	10.2	8.3	4.0	10.4
P / FCF	10.3	13.5	10.9	-32.4	45.9	11.5	18.6	54.9	17.9	11.6	5.5	22.7
EV / EBITDA	6.3	9.1	7.3	9.0	6.2	16.8	7.7	15.1	8.3	9.7	-21.5	8.0
EV / FCF	12.5	15.5	13.9	-43.5	61.9	16.9	25.0	66.9	21.2	14.2	8.1	29.7
EV / Revenue	1.3	1.7	1.2	1.1	1.1	1.1	1.0	1.4	1.5	1.7	1.0	1.2
Dividend Yield	2.4%	1.5%	2.3%	2.3%	2.8%	3.9%	3.1%	2.1%	2.2%	2.0%	2.8%	1.7%
Earnings Yield	7.9%	6.0%	11.2%	5.7%	8.7%	-11.7%	5.8%	-2.9%	7.0%	4.4%	-16.7%	6.0%
Payout Ratio	29.0%	24.5%	19.8%	40.2%	32.0%	-33.6%	51.0%	-70.8%	31.9%	43.6%	-16.8%	27.1%
Annual Payout	$96M	$93M	$88M	$84M	$80M	$80M	$80M	$80M	$77M	$65M	$56M	$54M

Gelir Tablosu 16

CBT için Çeyreklik Gelir Tablosu verileri
Metrik	Q2 2026	Q1 2025	Q4 2025	Q3 2025	Q2 2025	Q1 2024	Q4 2024	Q3 2024	Q2 2024	Q1 2023	Q4 2023	Q3 2023	Q2 2023	Q1 2022	Q4 2022	Q3 2022
Revenue	$904M	$849M	$899M	$923M	$936M	$955M	$1.00B	$1.02B	$1.02B	$958M	$965M	$968M	$1.03B	$965M	$1.11B	$1.15B
Cost of Revenue	$694M	$638M	$679M	$679M	$695M	$720M	$761M	$760M	$773M	$740M	$740M	$745M	$823M	$784M	$892M	$914M
Gross Profit	$210M	$211M	$220M	$244M	$241M	$235M	$240M	$256M	$246M	$218M	$225M	$223M	$210M	$181M	$220M	$235M
R&D Expense	$14M	$13M	$15M	$15M	$15M	$14M	$17M	$16M	$15M	$15M	$14M	$15M	$15M	$13M	$14M	$14M
SG&A Expense	$67M	$69M	$68M	$62M	$64M	$66M	$73M	$68M	$75M	$67M	$69M	$58M	$66M	$60M	$62M	$51M
Operating Income	$129M	$129M	$137M	$167M	$162M	$155M	$150M	$172M	$156M	$136M	$142M	$150M	$129M	$105M	$143M	$168M
Interest Expense	$18M	$18M	$20M	$19M	$19M	$18M	$19M	$19M	$21M	$22M	$21M	$24M	$23M	$22M	$18M	$15M
Other Non-op	$2M	·	$-9M	$0	$1M	$1M	$-3M	$-3M	$-1M	$-29M	$-3M	$-3M	$-5M	$-5M	$0	$-1M
Pretax Income	$120M	$118M	$115M	$155M	$151M	$144M	$135M	$158M	$142M	$94M	$127M	$130M	$110M	$84M	$129M	$152M
Income Tax	$44M	$37M	$63M	$43M	$49M	$41M	$-10M	$40M	$47M	$34M	$-118M	$41M	$29M	$20M	$29M	$49M
Net Income	$68M	$73M	$43M	$101M	$94M	$93M	$137M	$109M	$84M	$50M	$234M	$82M	$75M	$54M	$94M	$97M
EPS (Basic)	$1.27	$1.38	$0.80	$1.87	$1.71	$1.69	$2.45	$1.96	$1.50	$0.88	$4.10	$1.44	$1.31	$0.94	$1.66	$1.70
EPS (Diluted)	$1.27	$1.37	$0.80	$1.86	$1.69	$1.67	$2.41	$1.94	$1.49	$0.88	$4.08	$1.43	$1.29	$0.93	$1.66	$1.69
Shares (Basic)	52,000,000	52,700,000	-108,100,000	53,500,000	54,000,000	54,300,000	-110,700,000	55,100,000	55,400,000	55,300,000	-112,600,000	56,100,000	56,300,000	56,300,000	-113,200,000	56,300,000
Shares (Diluted)	52,200,000	52,900,000	-109,000,000	53,800,000	54,400,000	55,000,000	-111,600,000	55,700,000	55,800,000	55,800,000	-113,500,000	56,500,000	56,800,000	56,700,000	-113,800,000	56,800,000
EBITDA	$129M	$170M	·	$167M	$162M	$192M	·	$172M	$156M	$177M	·	$150M	$129M	$140M	·	$168M

Bilanço 26

CBT için Çeyreklik Bilanço verileri
Metrik	Q2 2026	Q1 2025	Q4 2025	Q3 2025	Q2 2025	Q1 2024	Q4 2024	Q3 2024	Q2 2024	Q1 2023	Q4 2023	Q3 2023	Q2 2023	Q1 2022	Q4 2022	Q3 2022
Cash & Equivalents	$252M	$230M	$258M	$239M	$213M	$183M	$223M	$197M	$206M	$244M	·	$220M	$205M	$190M	·	$208M
Inventory	$522M	$503M	$504M	$531M	$541M	$536M	$552M	$553M	$551M	$617M	·	$592M	$625M	$704M	·	$664M
Prepaid Expense	$116M	$108M	$106M	$114M	$110M	$100M	$97M	$109M	$104M	$105M	·	$102M	$145M	$127M	·	$123M
Current Assets	$1.55B	$1.46B	$1.54B	$1.57B	$1.60B	$1.50B	$1.60B	$1.59B	$1.60B	$1.69B	·	$1.60B	$1.74B	$1.80B	·	$1.87B
PP&E (Net)	$1.75B	$1.73B	$1.71B	$1.67B	$1.60B	$1.56B	$1.53B	$1.43B	$1.43B	$1.44B	·	$1.36B	$1.35B	$1.30B	·	$1.27B
PP&E (Gross)	$4.51B	$4.47B	$4.41B	$4.33B	$4.16B	$4.05B	$4.08B	$3.91B	$3.91B	$3.94B	·	·	·	·	·	·
Accum. Depreciation	$2.76B	$2.74B	$2.69B	$2.66B	$2.55B	$2.49B	$2.55B	$2.48B	$2.48B	$2.49B	·	·	·	·	·	·
Goodwill	$136M	$136M	$134M	$133M	$128M	$127M	$133M	$132M	$137M	$138M	$134M	$136M	$136M	$133M	$129M	$136M
Intangibles	$53M	$54M	$55M	$56M	$55M	$57M	$53M	$55M	$59M	$61M	·	$63M	$63M	$63M	·	$67M
Other Non-current Assets	$194M	$187M	$180M	$181M	$177M	$182M	$172M	$182M	$183M	$173M	·	$167M	$165M	$170M	·	$146M
Total Assets	$3.90B	$3.76B	$3.81B	$3.84B	$3.78B	$3.64B	$3.74B	$3.58B	$3.60B	$3.69B	$3.60B	$3.39B	$3.52B	$3.54B	$3.52B	$3.57B
Accounts Payable	$598M	$575M	$459M	$596M	$577M	$599M	$495M	$626M	$587M	$585M	·	$568M	$609M	$630M	·	$738M
Short-term Debt	$175M	$12M	$14M	$100M	$190M	$100M	$45M	$49M	$88M	$206M	·	$136M	$258M	$312M	·	$291M
Current Liabilities	$1.07B	$874M	$957M	$740M	$818M	$747M	$772M	$717M	$718M	$830M	·	$738M	$904M	$984M	·	$1.10B
Capital Leases	·	·	$85M	·	·	·	$88M	·	·	·	·	·	·	·	·	·
Deferred Tax	$40M	$43M	$39M	$40M	$39M	$39M	$42M	$40M	$38M	$51M	·	$60M	$58M	$65M	·	$73M
Other Non-current Liabilities	$239M	$257M	$258M	$269M	$247M	$252M	$245M	$244M	$245M	$241M	·	$230M	$231M	$236M	·	$255M
Long-term Debt	$1.12B	$1.11B	$1.09B	$1.11B	$1.10B	$1.10B	$1.09B	$1.09B	$1.10B	$1.11B	·	$1.10B	$1.10B	$1.10B	·	$1.12B
Total Debt	$1.30B	$1.13B	·	$1.22B	$1.29B	$1.20B	·	$1.14B	$1.18B	$1.31B	·	$1.24B	$1.36B	$1.41B	·	$1.41B
Common Stock	$52M	$52M	$53M	$53M	$54M	$54M	$54M	$55M	$55M	$55M	·	$56M	$56M	$57M	·	$56M
Retained Earnings	$1.83B	$1.84B	$1.83B	$1.85B	$1.80B	$1.77B	$1.73B	$1.68B	$1.63B	$1.58B	·	$1.41B	$1.36B	$1.31B	·	$1.21B
Treasury Stock	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	·	$3M	$3M	$4M	·	$3M
AOCI	$-316M	$-310M	$-335M	$-355M	$-427M	$-457M	$-360M	$-382M	$-317M	$-305M	·	$-329M	$-314M	$-358M	·	$-368M
Stockholders' Equity	$1.57B	$1.57B	$1.55B	$1.54B	$1.43B	$1.37B	$1.43B	$1.35B	$1.37B	$1.33B	·	$1.13B	$1.10B	$1.01B	·	$895M
Liabilities + Equity	$3.90B	$3.76B	$3.81B	$3.84B	$3.78B	$3.64B	$3.74B	$3.58B	$3.60B	$3.69B	·	$3.39B	$3.52B	$3.54B	·	$3.57B
Shares Outstanding	51,579,624	52,215,581	52,842,481	53,203,216	53,700,563	54,215,426	54,297,251	54,816,803	55,258,040	55,424,816	·	55,936,984	56,146,164	56,315,875	·	56,298,570

Nakit Akışı 19

CBT için Çeyreklik Nakit Akışı verileri
Metrik	Q2 2026	Q1 2025	Q4 2025	Q3 2025	Q2 2025	Q1 2024	Q4 2024	Q3 2024	Q2 2024	Q1 2023	Q4 2023	Q3 2023	Q2 2023	Q1 2022	Q4 2022	Q3 2022
D&A	$49M	$41M	$40M	$39M	$38M	$37M	$37M	$36M	$37M	$41M	$37M	$36M	$36M	$35M	$35M	$36M
Stock-based Comp	$4M	$3M	$5M	$5M	$6M	$8M	$6M	$6M	$7M	$6M	$5M	$3M	$6M	$6M	$6M	$6M
Deferred Tax	$-16M	$2M	$23M	$1M	·	·	$-44M	$-2M	$2M	$7M	$-155M	$2M	·	·	$-1M	$6M
Amort. of Intangibles	$1M	$2M	·	·	$2M	$2M	·	·	·	·	·	·	·	·	·	·
Restructuring	$8M	$7M	·	·	$3M	·	$0	$1M	$3M	$9M	·	·	·	·	·	·
Other Non-cash	·	$7M	·	·	·	$-14M	·	·	·	$1M	·	·	·	$-43M	·	·
Operating Cash Flow	$77M	$126M	$219M	$249M	$73M	$124M	$204M	$207M	$176M	$105M	$138M	$243M	$162M	$52M	$105M	$34M
CapEx	$45M	$69M	$64M	$61M	$72M	$77M	$92M	$52M	$43M	$54M	$78M	$80M	$51M	$35M	$90M	$50M
Investing Cash Flow	$-109M	$-69M	$-59M	$-65M	$-70M	$-104M	$-89M	$-51M	$-41M	$-54M	$-75M	$-75M	$-47M	$-17M	$-87M	$-46M
Debt Issued	·	·	$0	$9M	$0	$6M	$1M	$14M	$0	$0	$5M	·	·	·	$0	·
Net Debt Issued	·	$-2M	·	·	·	$5M	·	·	·	$-1M	·	·	·	$-6M	·	·
Stock Issued	·	·	$6M	$0	$0	$2M	$5M	$2M	$6M	$7M	$0	$0	$1M	$3M	$0	$3M
Stock Repurchased	$49M	$52M	$39M	$40M	$47M	$42M	$66M	$49M	$24M	$33M	$50M	$15M	$16M	$17M	$5M	$14M
Net Stock Activity	·	$-52M	·	·	·	$-40M	·	·	·	$-26M	·	·	·	$-14M	·	·
Dividends Paid	$24M	$24M	$25M	$24M	$23M	$24M	$24M	$24M	$23M	$22M	$23M	$23M	$21M	$21M	$21M	$21M
Financing Cash Flow	$53M	$-92M	$-146M	$-183M	$17M	$-24M	$-89M	$-131M	$-166M	$-29M	$-32M	$-161M	$-118M	$-92M	$16M	$44M
Net Change in Cash	$22M	$-28M	$19M	$26M	$30M	$-40M	$26M	$-9M	$-38M	$6M	$18M	$15M	$15M	$-16M	$-8M	$-1M
Free Cash Flow	·	$57M	·	·	·	$47M	·	·	·	$51M	·	·	·	$17M	·	·
Levered FCF	·	$45M	·	·	·	$34M	·	·	·	$37M	·	·	·	$238.1K	·	·

Kârlılık 8

CBT için Çeyreklik Kârlılık verileri
Metrik	Q2 2026	Q1 2025	Q4 2025	Q3 2025	Q2 2025	Q1 2024	Q4 2024	Q3 2024	Q2 2024	Q1 2023	Q4 2023	Q3 2023	Q2 2023	Q1 2022	Q4 2022	Q3 2022
Gross Margin	23.2%	24.9%	·	26.4%	25.8%	24.6%	·	25.2%	24.1%	22.8%	·	23.0%	20.3%	18.8%	·	20.4%
Operating Margin	14.3%	15.2%	·	18.1%	17.3%	16.2%	·	16.9%	15.3%	14.2%	·	15.5%	12.5%	10.9%	·	14.6%
Net Margin	7.5%	8.6%	·	10.9%	10.0%	9.7%	·	10.7%	8.2%	5.2%	·	8.5%	7.3%	5.6%	·	8.4%
Pretax Margin	13.3%	13.9%	·	16.8%	16.1%	15.1%	·	15.6%	13.9%	9.8%	·	13.4%	10.7%	8.7%	·	13.2%
EBITDA Margin	14.3%	20.0%	·	18.1%	17.3%	20.1%	·	16.9%	15.3%	18.5%	·	15.5%	12.5%	14.5%	·	14.6%
ROA	1.8%	2.0%	·	2.7%	2.5%	2.5%	·	3.1%	2.4%	1.4%	·	2.4%	2.1%	1.6%	·	2.9%
ROE	4.5%	5.0%	·	7.0%	6.7%	6.9%	·	8.8%	6.8%	4.3%	·	8.1%	7.4%	6.0%	·	10.5%
ROIC	2.9%	3.3%	·	4.4%	4.0%	4.3%	·	5.2%	4.1%	3.3%	·	4.3%	3.9%	3.3%	·	4.9%

Likidite ve Solventlik 5

CBT için Çeyreklik Likidite ve Solventlik verileri
Metrik	Q2 2026	Q1 2025	Q4 2025	Q3 2025	Q2 2025	Q1 2024	Q4 2024	Q3 2024	Q2 2024	Q1 2023	Q4 2023	Q3 2023	Q2 2023	Q1 2022	Q4 2022	Q3 2022
Current Ratio	1.4	1.7	·	2.1	2.0	2.0	·	2.2	2.2	2.0	·	2.2	1.9	1.8	·	1.7
Quick Ratio	0.2	0.3	·	0.3	0.3	0.2	·	0.3	0.3	0.3	·	0.3	0.2	0.2	·	0.2
Debt / Equity	0.8	0.7	·	0.8	0.9	0.9	·	0.8	0.9	1.0	·	1.1	1.2	1.4	·	1.6
LT Debt / Equity	0.6	0.5	·	0.7	0.8	0.8	·	0.8	0.8	0.8	·	1.0	1.0	1.1	·	1.2
Interest Coverage	7.2	7.2	·	8.8	8.5	8.6	·	9.1	7.4	6.2	·	6.2	5.6	4.8	·	11.2

Verimlilik 2

CBT için Çeyreklik Verimlilik verileri
Metrik	Eğilim	Q2 2026	Q1 2025	Q4 2025	Q3 2025	Q2 2025	Q1 2024	Q4 2024	Q3 2024	Q2 2024	Q1 2023	Q4 2023	Q3 2023	Q2 2023	Q1 2022	Q4 2022	Q3 2022
Asset Turnover		0.2	0.2	·	0.2	0.3	0.3	·	0.3	0.3	0.3	·	0.3	0.3	0.3	·	0.3
Inventory Turnover		1.3	1.2	·	1.3	1.3	1.2	·	1.3	1.3	1.1	·	1.2	1.3	1.3	·	1.6

Hisse Başına 6

CBT için Çeyreklik Hisse Başına verileri
Metrik	Q2 2026	Q1 2025	Q4 2025	Q3 2025	Q2 2025	Q1 2024	Q4 2024	Q3 2024	Q2 2024	Q1 2023	Q4 2023	Q3 2023	Q2 2023	Q1 2022	Q4 2022	Q3 2022
Book Value / Share	$30.40	$30.16	·	$28.96	$26.57	$25.20	·	$24.55	$24.74	$23.98	·	$20.22	$19.57	$17.92	·	$15.90
Revenue / Share	$17.32	$16.05	·	$17.16	$17.21	$17.36	·	$18.24	$18.26	$17.17	·	$17.13	$18.19	$17.02	·	$20.23
Cash Flow / Share	·	$2.38	·	·	·	$2.25	·	·	·	$1.88	·	·	·	$0.92	·	·
Cash / Share	$4.89	$4.40	·	$4.49	$3.97	$3.38	·	$3.59	$3.73	$4.40	·	$3.93	$3.65	$3.37	·	$3.69
Dividend Paid / Share	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
EPS (TTM)	$6.19	$6.59	·	$7.16	$6.79	$5.98	·	$5.74	$5.09	$4.53	·	$5.34	$5.75	$2.89	·	$3.44

Değerleme (TTM) 15

CBT için Çeyreklik Değerleme (TTM) verileri
Metrik	Q2 2026	Q1 2025	Q4 2025	Q3 2025	Q2 2025	Q1 2024	Q4 2024	Q3 2024	Q2 2024	Q1 2023	Q4 2023	Q3 2023	Q2 2023	Q1 2022	Q4 2022	Q3 2022
Revenue TTM	$3.61B	$3.66B	·	$3.83B	$3.93B	$3.95B	·	$3.96B	$3.98B	$3.92B	·	$4.12B	$4.24B	$4.17B	·	$4.13B
Net Income TTM	$336M	$361M	·	$397M	$380M	$336M	·	$325M	$291M	$261M	·	$308M	$333M	$169M	·	$201M
Market Cap	$3.88B	$3.46B	·	$3.99B	$4.46B	$4.95B	·	$5.04B	$5.09B	$4.63B	·	$3.74B	$4.30B	$3.76B	·	$3.59B
Enterprise Value	$4.93B	$4.36B	·	$4.97B	$5.54B	$5.97B	·	$5.98B	$6.07B	$5.70B	·	$4.76B	$5.46B	$4.98B	·	$4.79B
P/E	12.2	10.1	·	10.5	12.2	15.3	·	16.0	18.1	18.4	·	12.5	13.3	23.1	·	18.5
P/S	1.1	0.9	·	1.0	1.1	1.3	·	1.3	1.3	1.2	·	0.9	1.0	0.9	·	0.9
P/B	2.5	2.2	·	2.6	3.1	3.6	·	3.7	3.7	3.5	·	3.3	3.9	3.7	·	4.0
P / Tangible Book	2.8	2.5	·	3.0	3.6	4.2	·	4.3	4.4	4.1	·	4.0	4.8	4.6	·	5.2
P / Cash Flow	·	27.5	·	·	·	39.9	·	·	·	44.1	·	·	·	72.4	·	·
P / FCF	·	60.7	·	·	·	105.3	·	·	·	90.7	·	·	·	221.4	·	·
EV / EBITDA	38.2	25.6	·	29.7	34.2	31.1	·	34.8	38.9	32.2	·	31.7	42.3	35.6	·	28.5
EV / FCF	·	76.4	·	·	·	126.9	·	·	·	111.7	·	·	·	293.2	·	·
EV / Revenue	1.4	1.2	·	1.3	1.4	1.5	·	1.5	1.5	1.5	·	1.2	1.3	1.2	·	1.2
Earnings Yield	8.2%	9.9%	·	9.6%	8.2%	6.6%	·	6.2%	5.5%	5.4%	·	8.0%	7.5%	4.3%	·	5.4%
Payout Ratio	·	32.9%	·	·	·	25.8%	·	·	·	44.0%	·	·	·	38.9%	·	·

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

Gelir Tablosu

	2025-09-30	2024-09-30	2023-09-30	2022-09-30	2021-09-30
Gelir	$3.71B	$3.99B	$3.93B	$4.32B	$3.41B
Brüt Kâr Marjı %	25.3%	24.0%	21.3%	20.5%	23.4%
Faaliyet Kâr Marjı %	16.7%	15.4%	13.4%	9.0%	13.3%
Net Gelir	$331M	$380M	$445M	$209M	$250M
Seyreltilmiş Hisse Başı Kâr	$6.02	$6.72	$7.73	$3.62	$4.34

Bilanço

	2025-09-30	2024-09-30	2023-09-30	2022-09-30	2021-09-30
Borç / Öz Sermaye	0.7	0.8	1.0	1.6	1.2
Cari Oran	1.6	2.1	2.0	1.6	1.2
Cari Oran	0.3	0.3	0.3	0.2	0.1

Nakit Akışı

	2025-09-30	2024-09-30	2023-09-30	2022-09-30	2021-09-30
Serbest Nakit Akışı	$391M	$451M	$351M	$-111M	$62M

Son Haberler Bu şirketten bahseden son manşetler

Buğday Ticareti Çarşamba Sabahı Karışık Seyrediyor Yahoo Finance · 1 ay, 2 hafta önce
Pazartesi Sabahı Kazançlarıyla Buğday Ticareti Yahoo Finance · 1 ay, 3 hafta önce
Buğday Ticareti Öğle Vaktinde Çoğunlukla Yükselişte Yahoo Finance · 2 ay önce
Buğday Pazartesi Günlük Kazançlar Yahoo Finance · 2 ay, 1 hafta önce

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar

📊

Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.

Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.

CBT Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

CBT Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

Hareketli ortalamalar ve bindirmeler

Hacim

Osilatörler

Momentum ve eğilim

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC

Finansal Sağlık Borç, likidite, solventlik — bilanço gücü

Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR

Hisse Başı Metrikler Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü

Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı

Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR

CBT Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

12 Aylık Fiyat Hedefi

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

Son Haberler Bu şirketten bahseden son manşetler

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar